Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.
about
Rituximab for thyroid-associated ophthalmopathyRituximab for thyroid-associated ophthalmopathyAtacicept: targeting B cells in multiple sclerosisUnraveling effector functions of B cells during infection: the hidden world beyond antibody productionTreatment options and strategies for antibody mediated rejection after renal transplantationRituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathyEmerging viral infections of the central nervous system: part 2Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation.NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell TransplantatioB-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection.Human T-follicular helper and T-follicular regulatory cell maintenance is independent of germinal centersInhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes.A small CD11b(+) human B1 cell subpopulation stimulates T cells and is expanded in lupusB Lymphocytes Are Required during the Early Priming of CD4+ T Cells for Clearance of Pneumocystis Infection in Mice.Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapyIn vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy.Effect of B-cell depletion on viral replication and clinical outcome of simian immunodeficiency virus infection in a natural host.Temporal requirements for B cells in the establishment of CD4 T cell memory.Of mice and men: how animal models advance our understanding of T-cell function in RA.Advances in diagnosing and managing antibody-mediated rejection.Increased Circulating T Follicular Helper Cells Are Inhibited by Rituximab in Neuromyelitis Optica Spectrum Disorder.Effector and regulatory B cells: modulators of CD4+ T cell immunity.Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use.B cells as effectors and regulators of autoimmunity.B cells participate in tolerance and autoimmunity through cytokine production.Current and prospective pharmacotherapy for autoimmune hepatitis.Peripheral immature B cells: modulators of autoimmunity.Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises.Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment.Regulatory T Cells in SLE: Biology and Use in Treatment.Antigen presentation by B cells guides programing of memory CD4+ T-cell responses to a TLR4-agonist containing vaccine in mice.Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric study.B-lymphocyte reconstitution after repeated rituximab treatment in a child with steroid-dependent autoimmune hemolytic anemia.Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome.Rituximab use in patients with ANCA-associated vasculitis: clinical efficacy and impact on immunological parameters.Anti-CD20 antibody is an efficient therapeutic tool for the selective removal of autoreactive T cells.Anti-JC virus antibodies in rituximab-treated patients with neuromyelitis optica spectrum disorder.B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis.B-cell depletion therapy in systemic sclerosis: experimental rationale and update on clinical evidence.
P2860
Q24202845-CC70EEA1-6635-460A-B629-E0B94F575262Q24235160-9D26A7CB-D81F-4AFA-B3A9-F59252995445Q24628925-2AAF8CB3-C791-4A89-B034-3A7953E05819Q27010202-D65567FB-73DD-4F84-8CAC-102B65C7EF4AQ27021397-ACCA5506-A8FF-4B54-9BCF-93066C7931AEQ33624477-19B2BD05-CBE7-4B4E-8CB4-226400A992B8Q33877744-0517D997-79BA-4C50-B083-452E616166E3Q34052870-B68F1BF5-23FD-4AEA-AF39-02C9E841CFAAQ34149280-D2EF96F8-5011-406D-A630-E71F033A9548Q34202277-E04BDDBD-95CE-4CC2-81A2-A6C255CDE6B0Q34239109-47CC4B97-2452-49A8-85BE-BE2E3B769987Q34398374-3E783A3B-239E-4AE6-9CA3-C67E745B1107Q35053311-69DF81DD-1EEF-47EE-9044-507A55DEFD56Q35627702-A69013C4-60DE-4D21-B4BA-BCA27782316CQ35816029-AFE9B0F4-CB75-495A-A011-2A9065315661Q37075975-D767A671-0695-41FF-A281-B0E21278972AQ37086932-32C64C2A-843A-4B60-BD70-F0E33AC94FD5Q37365356-332F5C2D-BF88-4B21-8568-A2679A5801CCQ37399047-BEE23F22-AC7B-4F37-9777-37664077DDBBQ37635735-3BB777B5-108E-4F29-8178-893E077165B6Q37676032-13FCD6B3-6C34-4709-A302-BA79D4C1AEDBQ37699554-A00D322A-8F36-4E0F-A97E-D9E9EBEB541FQ37708012-7063E7F4-B36F-447B-813A-DBA3AB9A910DQ37906737-CCA789F9-3915-4C77-8D78-CC784D6397FFQ37995319-F4D3B7B7-FD70-4C43-9A37-2389FECF8683Q38163603-A0C66124-4C6A-427B-BE1F-DF9C3BE476A6Q38222882-120A6423-A3A0-4E8D-BE9D-D4A706419397Q38257826-8DB80811-3C5F-44F0-A87C-6DAD53859CF3Q38824182-66999F90-E7AA-4038-B829-A90E566576EDQ38933668-C2CA6E54-C9D1-4BAB-8BAB-D484C1001CF7Q38972466-5FE1110B-A68F-42A7-A035-BA90E86B6D45Q40517477-CE5CCA33-9FA4-47C6-B84E-35655DB9B0B1Q40962973-B39001E3-B771-4F6E-96A6-08CFE96788F9Q41344044-75CD5AFB-7495-4BA6-A979-A31D3EE3EBF1Q41662842-730C13EF-4CB3-4EA9-BB10-D4079C06C915Q41667048-5E626FBF-33B7-4664-874E-C7D8CDDD2BF8Q42060871-9437185C-5E68-4087-A80C-25EC1A4D2056Q42175650-1ABCDD87-130A-474F-9DA1-92D4EC073B3AQ42771422-6F614905-023C-4CE8-8D25-E6D16ECDF199Q42855117-FDC6B2CF-2970-4825-AE13-BC3E54182A32
P2860
Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.
@en
Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.
@nl
type
label
Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.
@en
Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.
@nl
prefLabel
Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.
@en
Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.
@nl
P1433
P1476
Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells
@en
P2093
Petros P Sfikakis
P304
P356
10.1016/J.CLIM.2008.01.011
P577
2008-03-11T00:00:00Z